SCHEMBL17637845

SCHEMBL17637845

O=c1oc2c3cc(-c4cc(-c5ccccc5)cc(-c5ccccc5)c4)ccc3ccc2c2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 6/20 0.48
CYP1B1 Q16678 6/20 0.48
CYP1A2 P05177 5/20 0.48
ABCG2 Q9UNQ0 3/20 0.48
CYP19A1 P11511 2/20 0.48
ALDH1A1 P00352 2/20 0.48
HPGD P15428 2/20 0.48
PRKDC P78527 2/20 0.48
ABCC1 P33527 2/20 0.48
KDM4E B2RXH2 1/20 0.48
PDE5A O76074 1/20 0.48
TP53 P04637 1/20 0.48
ABCB1 P08183 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
MAPT P10636 1/20 0.48
CYP2C9 P11712 1/20 0.48
TSHR P16473 1/20 0.48
CYP2B6 P20813 1/20 0.48
TACR2 P21452 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17637664 0.79 L3MBTL1 (0.46) CYP1A1CYP1B1CYP1A2ABCG2CYP19A1
SCHEMBL17384169 0.79 HPRT1 (0.56) CYP1A1CYP1B1CYP1A2ABCG2CYP19A1
SCHEMBL3081576 0.79 ARSA (0.56) CYP1A1CYP1B1CYP1A2ABCG2CYP19A1
SCHEMBL17384172 0.79 HPRT1 (0.56) CYP1A1CYP1B1CYP1A2ABCG2CYP19A1
SCHEMBL19080124 0.78 CYP1A1 (0.38) CYP1A1CYP1B1CYP1A2ABCG2CYP19A1
SCHEMBL17637819 0.77 PLA2G2A (0.54) CYP1B1ABCG2CYP19A1ALDH1A1HPGD
SCHEMBL25460310 0.77 CYP1A1 (0.48) CYP1A1CYP1B1CYP1A2ABCG2CYP19A1
SCHEMBL19079941 0.75 CYP1A2 (0.38) CYP1A1CYP1B1CYP1A2ABCG2CYP19A1
SCHEMBL23134229 0.74 PLA2G2A (0.40) CYP1A1CYP1B1CYP1A2ABCG2CYP19A1
SCHEMBL27050226 0.74 CYP1A1 (0.51) CYP1A1CYP1B1CYP1A2ABCG2CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10377766-B2 Heterocyclic compounds with benzo(c)coumarin-structures MERCK PATENT GMBH (DE) 2019-08-13 US disclosed
US-20170298077-A1 HETEROCYCLIC COMPOUNDS WITH BENZO(C)COUMARIN-STRUCTURES MERCK PATENT GMBH (DE) 2017-10-19 US disclosed
US-20170298077-A1 HETEROCYCLIC COMPOUNDS WITH BENZO(C)COUMARIN-STRUCTURES MERCK PATENT GMBH (DE) 2017-10-19 US disclosed
WO-2016045769-A1 HETEROCYCLIC COMPOUNDS WITH BENZO[C]COUMARIN-STRUCTURES MERCK PATENT GMBH (DE) 2016-03-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170298077-A1 HETEROCYCLIC COMPOUNDS WITH BENZO(C)COUMARIN-STRUCTURES NISCH, SIRT3, NQO1 CYP1A1 92/4885CYP1B1 94/4885CYP1A2 66/4885
US-10377766-B2 Heterocyclic compounds with benzo(c)coumarin-structures NISCH, SIRT3, NQO1 CYP1A1 92/4885CYP1B1 94/4885CYP1A2 66/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.